Risk Factors Can ID Patients More Likely to Be Readmitted

This article originally appeared here.
Share this content:
Risk Factors Can ID Patients More Likely to Be Readmitted
Risk Factors Can ID Patients More Likely to Be Readmitted

(HealthDay News) -- Patients at greatest risk for an unplanned hospital readmission include those with chronic cardiovascular and pulmonary diseases, those discharged on Fridays, and those with a high number of previous emergency department visits, according to a study published in the August issue of the Journal of Evaluation in Clinical Practice.

Anja Braet M.D., from KU Leuven-University of Leuven in Belgium, and colleagues analyzed data from the Belgian Hospital Discharge Dataset (1,130,491 patients discharged in 2008) in order to identify patient and hospital factors contributing to readmission rates.

The researchers found that the overall unplanned readmission rate was 5.2 percent. The most common reasons for readmission were cardiovascular and pulmonary diagnoses, and 10.4 percent of all readmissions were due to complications. The strongest predictor of readmission was a high number of previous emergency department visits (odds ratio for patients with at least four emergency department visits in the past six months, 4.65). Other predictors of a higher risk for readmission included discharge on Friday (odds ratio, 1.05) and a long length of stay (odds ratio, 1.19).

"Actions to reduce readmissions can be targeted to patient groups at risk, and should be aimed at the caring for chronic cardiovascular or pulmonary diseases, preventing complications and multiple emergency department visits, and ensuring continuity of care after discharge, especially for patients discharged on Friday," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »